IRIS Accounts Production v24.2.0.383 14745942 Board of Directors 21.3.23 31.3.24 31.3.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh147459422023-03-20147459422024-03-31147459422023-03-212024-03-31147459422023-03-2014745942ns15:EnglandWales2023-03-212024-03-3114745942ns14:PoundSterling2023-03-212024-03-3114745942ns10:Director12023-03-212024-03-3114745942ns10:PrivateLimitedCompanyLtd2023-03-212024-03-3114745942ns10:Micro-entities2023-03-212024-03-3114745942ns10:AuditExempt-NoAccountantsReport2023-03-212024-03-3114745942ns10:FullAccounts2023-03-212024-03-3114745942ns5:CurrentFinancialInstruments2024-03-3114745942ns10:RegisteredOffice2023-03-212024-03-31
REGISTERED NUMBER: 14745942 (England and Wales)















Unaudited Financial Statements for the Period 21 March 2023 to 31 March 2024

for

Metronomia Clinical Research (UK) Ltd.

Metronomia Clinical Research (UK) Ltd. (Registered number: 14745942)






Contents of the Financial Statements
for the Period 21 March 2023 to 31 March 2024




Page

Statement of Financial Position 1


Metronomia Clinical Research (UK) Ltd. (Registered number: 14745942)

Statement of Financial Position
31 March 2024

£   
CALLED UP SHARE CAPITAL NOT PAID 100

CURRENT ASSETS 19,749

CREDITORS
Amounts falling due within one year (7,430 )
NET CURRENT ASSETS 12,319
TOTAL ASSETS LESS CURRENT
LIABILITIES

12,419

CAPITAL AND RESERVES 12,419

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

Metronomia Clinical Research (UK) Ltd. is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 14745942

Registered office: C/O Cantelowes Limited
4th Floor
20 Aldermanbury
London
EC2V 7HY

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 2 .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 23 September 2024 and were signed on its behalf by:





M Niemeier - Director